Compounds > 4-butyrolactone
Page last updated: 2024-08-18

4-butyrolactone and Ischemic Stroke

4-butyrolactone has been researched along with Ischemic Stroke in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's2 (100.00)2.80

Authors

AuthorsStudies
Liu, J; Mao, Z; Seto, S; Tian, L; Wang, G; Wang, N; Wang, Y; Wu, Q2

Other Studies

2 other study(ies) available for 4-butyrolactone and Ischemic Stroke

ArticleYear
Ligustilide attenuates ischemic stroke injury by promoting Drp1-mediated mitochondrial fission via activation of AMPK.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2022, Volume: 95

    Topics: 4-Butyrolactone; AMP-Activated Protein Kinases; Animals; Apoptosis; Brain Ischemia; Dynamins; Ischemic Stroke; Mitochondrial Dynamics; Rats

2022
Ligustilide ameliorates hippocampal neuronal injury after cerebral ischemia reperfusion through activating PINK1/Parkin-dependent mitophagy.
    Phytomedicine : international journal of phytotherapy and phytopharmacology, 2022, Volume: 101

    Topics: 4-Butyrolactone; Animals; Brain Ischemia; Hippocampus; Infarction, Middle Cerebral Artery; Ischemic Stroke; Mammals; Mitophagy; Protein Kinases; Rats; Reperfusion; Reperfusion Injury; Ubiquitin-Protein Ligases

2022